As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Announcement: COVID-19 impact on peer review
Announcing the launch of In Review
Cell Communication and Signaling, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Aims and Scope
Cell Communication and Signaling (CCS) is an open access journal that encompasses all basic and translational aspects of cellular communications and signaling pathways in normal and pathological conditions.
Beginning in January of 2019, CCS is pleased to announce their affiliation with the International Cell Death Society.
The journal encourages submissions in all aspects of cell death, that include apoptotic and non-apoptotic mechanisms of cell death, cell death in model systems, autophagy, clearance of dying cells, as well as the immunological and pathological consequences of dying cells in the tissue microenvironment.
Suggest a topic here
Biology of phosphatidylserine: basic physiology and implications in immunology, infectious disease, and cancer
Edited by Raymond Birge and David Calianese
25th Anniversary of the ICDS Cell Death collection
Edited by Raymond Birge
Pluripotent Stem Cells: Research Review
Tumor Cell-Microenvironment Communication
Edited by Silja Wessler
Short linear motifs - the unexplored frontier of the eukaryotic proteome
Edited by Norman Davey
Bacterial pathogen - host cell interactions
Edited by Silja Wessler
Systems Biology and Medicine
Edited by Stephan Feller and Fred Schaper
Interaction of Helicobacter pylori with its host cell
Edited by Silja Wessler
Cancer cell motility and microenvironment
Call for papers
Kinases, adaptor proteins, and actin cytoskeleton rearrangements in EMT and cancer
Edited by Dr. Leszek Kotula and Dr. Patrycja Dubielecka-Sczerba
The roles of intrinsically disordered proteins and regions (IDPs and IDRs) in cell communication and cell signaling
Edited by Dr. Sarah Bondos, Dr. A. Keith Dunker and Dr. Vladimir Uversky
Biology of phosphatidylserine (PS): basic physiology and implications in immunology, infectious disease, and cancer
Edited by Dr. Raymond Birge and Dr. David Calianese
Video Bytes are here
At Cell Communication and Signaling, we are passionate about the dissemination of research.
We are pleased to announce that as of the 12th August 2019, all authors whose papers are accepted will receive a Video Byte.
Created by our partners, Research Square, a Video Byte is a 1-2 minute video summary of a paper that will be incorporated into the abstract of the paper and published on the journal website. Authors will also receive a shareable version of their Video Byte.
Curated by Editor-in-Chief Raymond Birge, we're celebrating the 25th anniversary of the ICDS with a collection highlighting the most important Cell Death papers published in Cell Communication and Signaling in the last decade.
In this recent paper, Lindner et al. examined how the ER stressor thapsigargin and therapy-relevant analogs induce cell death in human cancer cells. They revealed crucial roles for DR5 and MAP1LC3B upstream of caspase-8. Upregulation of DR5 and MAP1LC3B required independent contributions from ATF4 and CHOP, while PERK elicited pro-death signals via other mechanisms. IRE1 and XBP1 promoted death in a cell type-specific manner, via a novel identified XBP1-dependent activation of JNK.
Raymond Birge, Editor-in-Chief
Raymond Birge, PhD., is a Professor at Rutgers, The State University of New Jersey and member of the New Jersey Medical School Cancer Center. Dr. Birge joined UMDNJ-New Jersey Medical School in 2000 and currently holds a position of Professor and Vice Chair for Research in the Department of Microbiology, Biochemistry and Molecular Biology. Dr. Birge also has joint appointments at the New Jersey Medical School Cancer Center (Newark) and the Cancer Institute of New Jersey (New Brunswick).
Annual Journal Metrics
46 days to first decision for reviewed manuscripts only
25 days to first decision for all manuscripts
105 days from submission to acceptance
20 days from acceptance to publication
367 Altmetric mentions